One-step ELISA Market

One-step ELISA Market Snapshot

The global one-step ELISA market size is anticipated to reach US$ 9.4 Billion in 2032 and exhibit steady growth at a CAGR of 3.8% in the forecast period from 2022 to 2032. Increasing research activities in the field of biomarkers are projected to drive the one-step ELISA market in future. According to FMI, sales in one-step ELISA are likely to be valued at US$ 6.3 Billion in 2022.

Report Attribute	Details
One-step ELISA Market Estimated Base Year Value (2021)	US$ 5.1 Billion
One-step ELISA Market Expected Market Value (2022)	US$ 6.3 Billion
One-step ELISA Market Anticipated Forecast Value (2032)	US$ 9.4 Billion
One-step ELISA Market Projected Growth Rate (2022-2032)	3.8% CAGR

Enzyme-Linked Immunosorbent Assay, commonly known as ELISA, is considered to be one of the gold standards for in-vitro diagnostic testing. Despite the ongoing development of point of care, microfluidics, immunosensors, and lab-on-chip technologies, ELISA is currently showcasing high demand.

The increasing prevalence of various infectious and chronic diseases worldwide is anticipated to push the demand for one-step ELISA in the upcoming years. The high demand for relatively low cost diagnostic tools in emerging economies is also expected to drive the market.

ELISA has high throughput and unmatched reliability for the management and monitoring of disease markers. In conventional assays, microplates are usually coated with antibodies that bind to the selected target proteins.

Antibodies that bind to a different site on the target protein are utilized for the detection of bound proteins. But, the modern one-step ELISA has simplified this process.

This type of test is performed with the help of a semi-homogeneous mixture wherein the sandwich complex is formed in one step. It is then anchored to the plate for identification with immunoaffinity tags.

Is Rising Prevalence of HIV/AIDS Driving the One-step ELISA Market Growth

The rising prevalence of HIV/AIDS across the globe is anticipated to boost the one-step ELISA market growth in the assessment period. As per the World Health Organization (WHO), in 2020, approximately 37.7 million people were living with HIV/AIDS globally, while 680,000 people had died of HIV-related illnesses the same year. These numbers are estimated to surge in future years, thereby augmenting the market.

In addition to that, the sudden outbreak of the COVID-19 pandemic in December 2019 led to the increasing usage of ELISA for the rapid detection of coronavirus. The massive approvals, valuations, and research activities associated with multiple immunoassay analyzers and consumables backed by the rising cases of COVID-19 is also likely to accelerate the market.

How Are Technological Hurdles Challenging the One-step ELISA Market Growth

Government bodies of various countries across the globe are expected to put forward stringent norms for the commercialization and approval of immunoassay instruments and consumables.

Numerous technological challenges posed by the immunoassay kits and reagents, including false negatives, low detection limits of the available antibodies, and cross-reactivity of antibodies are also expected to hamper the one-step ELISA market size in the evaluation period.

How is Geriatric Population Accelerating the North America One-step ELISA Market

Based on region, North America is expected to account for the largest one-step ELISA market share in the forthcoming years. The rising geriatric population in the U.S. and Canada and increasing investments in the development of their healthcare infrastructure are anticipated to propel the regional market.

According to the U.S. Department of Health and Human Services, the population belonging to the age group of 65 years and above was 54.1 million in 2019 in this country, including 24.1 million men and 30 million women. This trend is set to continue throughout the forthcoming years, thereby propelling the North America market.

Is Rising Childbirth in India Spurring the Asia Pacific One-step ELISA Market

Sales of one-step ELISA are anticipated to surge in Asia Pacific on the back of presence of various prominent market participants in India and China. In October 2020, Cipla Limited, for instance, commercialized its new antibody detection kits by joining hands with KARWA Ltd. in India for COVID-19. Thus, the development and commercialization of multiple products by key companies in this region is set to drive the market.

The high demand for pregnancy tests in Asia Pacific owing to the urgent need for early diagnosis is another major factor that is anticipated to propel the market. As per UNICEF, India accounts for nearly one fifth of the annual child births in the world with the birth of 25 million children every year. It is expected to grow in future, thereby fostering growth.

Market Competition

The global one-step ELISA market contains a large number of key players. Some of them are AnaSpec, Inc., Abcam plc, InBios International, Inc., Boster Biological Technology, PerkinElmer, Inc., DIALAB GmbH, and IDS PLC among others.

Majority of the leading players are engaging in joint ventures, collaborations, and mergers and acquisitions to gain a competitive edge in the market. A few other key players are aiming to develop innovative products to expand their product portfolios and generate high shares in the market.

Meanwhile, some of the large-scale enterprises are expanding their distribution channels and production capacities to cater to the surging consumer demand.

Report Scope

Report Attribute	Details
Growth Rate	CAGR of 3.8% from 2022 to 2032
Base Year for Estimation	2021
Historical Data	2015-2020
Forecast Period	2022-2032
Quantitative Units	Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032
Report Coverage	Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segments Covered	Target Sample Type End User Region
Regions Covered	North America Latin America Western Europe Eastern Europe APEJ Japan Middle East and Africa
Key Countries Profiled	U.S Canada Brazil Argentina Germany U.K France Spain Italy Nordics BENELUX Australia & New Zealand China India ASEAN GCC South Africa
Key Companies Profiled	AnaSpec, Inc. Abcam plc InBios International, Inc. Boster Biological Technology PerkinElmer, Inc. DIALAB GmbH IDS PLC
Customization	Available Upon Request

Key Segments Profiled in the One-step ELISA Industry Survey

By Target:

• IgG
• Albumin
• TNF Alpha
• IL-6
• Fibrinogen
• Insulin
• Lysozyme
• Others

By Sample Type:

• Serum or Plasma
• Tissue Lysate
• Others

By End User:

• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Diagnostic Centers
• Hospitals & Clinics

By Region:

• North America
• Latin America
• Western Europe
• Eastern Europe
• APEJ
• Japan
• Middle East and Africa